Analytical Data
-
Gene name
MSRB7
- Application
-
Alternative Names
Peptide-methionine (R)-S-oxide reductase
-
Species
Arabidopsis thaliana
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8VY86
-
Expression Region
1-144aa
-
Molecular Weight
31.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MSRB7 (Methionine Sulfoxide Reductase B7) is a member of the methionine sulfoxide reductase family, which plays a crucial role in protecting cells from oxidative damage by reducing oxidized methionine residues back to their active form. This protein has garnered significant attention in recent years due to its involvement in various physiological processes, including cell signaling, apoptosis, and stress responses. The accumulation of oxidative stress is linked to numerous diseases, including neurodegenerative disorders and cancer, making MSRB7 a potential therapeutic target for mitigating these conditions. Research has highlighted the enzyme's distinct characteristics, such as its unique substrate specificity and tissue distribution, suggesting that it may have specialized functions in different cellular contexts. Furthermore, studies have begun to elucidate the regulatory mechanisms underlying MSRB7 activity, revealing its potential interactions with other biomolecules and signaling pathways. Understanding the structural and functional aspects of MSRB7 can provide insights into its role in cellular homeostasis and disease progression. Consequently, the ongoing research into MSRB7’s biochemical properties, genetic regulation, and therapeutic applications aims to uncover novel strategies for disease prevention and treatment through the modulation of oxidative stress responses.
